For research use only. Not for therapeutic Use.
ML191(Cat No.:R061158)is a selective inverse agonist of GPR55, an orphan G protein-coupled receptor implicated in inflammation, pain signaling, cancer progression, and bone physiology. By inhibiting GPR55-mediated signaling, ML191 reduces downstream effects such as cell proliferation and migration, offering potential therapeutic relevance in oncology and inflammatory disorders. With minimal off-target activity on classical cannabinoid receptors (CB1 and CB2), ML191 is widely used in research to investigate GPR55-specific pathways and validate it as a drug target. It serves as a valuable tool in studies exploring non-cannabinoid GPCR modulation and disease mechanisms.
CAS Number | 931695-79-3 |
Synonyms | 3-[1-[1-(4-methylphenyl)cyclopropanecarbonyl]piperidin-4-yl]-5-phenyl-1,3,4-oxadiazol-2-one |
Molecular Formula | C24H25N3O3 |
Purity | ≥95% |
IUPAC Name | 3-[1-[1-(4-methylphenyl)cyclopropanecarbonyl]piperidin-4-yl]-5-phenyl-1,3,4-oxadiazol-2-one |
InChI | InChI=1S/C24H25N3O3/c1-17-7-9-19(10-8-17)24(13-14-24)22(28)26-15-11-20(12-16-26)27-23(29)30-21(25-27)18-5-3-2-4-6-18/h2-10,20H,11-16H2,1H3 |
InChIKey | WWJKJCDOYFKZBJ-UHFFFAOYSA-N |
SMILES | CC1=CC=C(C=C1)C2(CC2)C(=O)N3CCC(CC3)N4C(=O)OC(=N4)C5=CC=CC=C5 |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |